Back to top
more

OraSure Technologies (OSUR)

(Delayed Data from NSDQ)

$3.38 USD

3.38
1,078,949

+0.08 (2.42%)

Updated Sep 19, 2025 04:00 PM ET

After-Market: $3.38 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (151 out of 245)

Industry: Medical - Products

Zacks News

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for February 27th

Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, February 27th:

    Zacks Equity Research

    Surging Earnings Estimates Signal Good News for OraSure (OSUR)

    OraSure (OSUR) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.

      Zacks Equity Research

      5 Top Stocks with Upgraded Broker Ratings to Bet On

      When brokers upgrade a stock, you can rely on their judgment.

        Ryan McQueeney headshot

        Stock Market Roundup, Feb. 14: Stocks Spread the Love on Valentine's Day

        Valentine's Day is not everyone???s favorite holiday, but investors should be pleased either way after a relatively solid day on the stock market.

          Zacks Equity Research

          Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies

          Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies

            Nilanjan Choudhury headshot

            Want to Gain from Relative Price Strength? 5 Stocks to Buy

            We ran a screen to select the top 5 stocks with solid relative price strength you want to have.

              Zacks Equity Research

              AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag

              AmerisourceBergen Corporation (ABC) posted earnings (excluding one-time items) of $1.36 per share in the first quarter of fiscal 2017, beating the Zacks Consensus Estimate of $1.24.

                Zacks Equity Research

                Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins

                Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins

                  Zacks Equity Research

                  Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates

                  Hill-Rom Holdings, Inc. (HRC) reported first-quarter fiscal 2017 adjusted earnings per share of 75 cents, up 10.3% from the year-ago quarter.

                    Zacks Equity Research

                    Abaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss

                    Abaxis, Inc. (ABAX) - a global provider of point-of-care blood analyzers - reported third-quarter fiscal 2017 earnings per share of 30 cents, in line with the Zacks Consensus Estimate.

                      Zacks Equity Research

                      5 Efficient Stocks Potent Enough to Boost Your Returns

                      A portfolio built by investing in efficient companies is capable of generating profits irrespective of market conditions.

                        Zacks Equity Research

                        Cardiovascular Systems (CSII) Q2 Earnings Better Estimates

                        Cardiovascular Systems, (CSII) reported earnings per share of 3 cents in second-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's loss of 47 cents.

                          Zacks Equity Research

                          Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17

                          Mead Johnson (MJN) reported fourth-quarter 2016 adjusted EPS of 78 cents, missing the Zacks Consensus Estimate of 83 cents by 6%.

                            Zacks Equity Research

                            Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View

                            Quest Diagnostics' (DGX) fourth-quarter 2016 adjusted earnings per share (EPS) of $1.31 came in 4 cents ahead of the Zacks Consensus Estimate.

                              Zacks Equity Research

                              PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues

                              PetMed Express (PETS) announced earnings per share (EPS) of 24 cents for the third quarter of fiscal 2017.

                                Zacks Equity Research

                                Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line

                                Abbott Laboratories (ABT) reported fourth-quarter 2016 earnings from continuing operations of 65 cents per share, a penny higher than the Zacks Consensus Estimate.

                                  Zacks Equity Research

                                  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2

                                  ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.

                                    Brian Bolan headshot

                                    Bull of the Day: OraSure (OSUR)

                                    This stock is the perfect example of the post earnings drift even after a huge move on the earnings report.

                                      Kevin Matras headshot

                                      A Company's First Profit Can Mean Big Profits to Investors

                                      Kevin Matras screens for companies showing their 'first' profit, and explains why they are ones to watch. Highlighted stocks include OPHT, XNPT, OSUR, INCY and AGIO.